PYC Therapeutics Limited (ASX:PYC)

PYC Therapeutics Statistics

Total Valuation

ASX:PYC has a market cap or net worth of AUD 746.57 million. The enterprise value is 594.98 million.

Market Cap	746.57M
Enterprise Value	594.98M

Important Dates

The next estimated earnings date is Friday, August 29, 2025.

Earnings Date	Aug 29, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:PYC has 583.26 million shares outstanding. The number of shares has increased by 27.16% in one year.

Current Share Class	583.26M
Shares Outstanding	583.26M
Shares Change (YoY)	+27.16%
Shares Change (QoQ)	+14.51%
Owned by Insiders (%)	35.86%
Owned by Institutions (%)	2.45%
Float	348.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	31.78
PB Ratio	4.39
P/TBV Ratio	4.50
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-11.83
EV / Sales	25.32
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-11.33

Financial Position

The company has a current ratio of 14.41, with a Debt / Equity ratio of 0.01.

Current Ratio	14.41
Quick Ratio	14.38
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.02
Interest Coverage	-861.87

Financial Efficiency

Return on equity (ROE) is -40.64% and return on invested capital (ROIC) is -26.48%.

Return on Equity (ROE)	-40.64%
Return on Assets (ROA)	-24.42%
Return on Invested Capital (ROIC)	-26.48%
Return on Capital Employed (ROCE)	-31.37%
Revenue Per Employee	4.70M
Profits Per Employee	-10.06M
Employee Count	5
Asset Turnover	0.17
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.48% in the last 52 weeks. The beta is 0.56, so ASX:PYC's price volatility has been lower than the market average.

Beta (5Y)	0.56
52-Week Price Change	-4.48%
50-Day Moving Average	1.31
200-Day Moving Average	1.29
Relative Strength Index (RSI)	47.56
Average Volume (20 Days)	502,848

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:PYC had revenue of AUD 23.49 million and -50.30 million in losses. Loss per share was -0.10.

Revenue	23.49M
Gross Profit	23.49M
Operating Income	-53.63M
Pretax Income	-51.01M
Net Income	-50.30M
EBITDA	-52.88M
EBIT	-53.63M
Loss Per Share	-0.10

Balance Sheet

The company has 153.05 million in cash and 1.02 million in debt, giving a net cash position of 152.03 million or 0.26 per share.

Cash & Cash Equivalents	153.05M
Total Debt	1.02M
Net Cash	152.03M
Net Cash Per Share	0.26
Equity (Book Value)	170.01M
Book Value Per Share	0.29
Working Capital	165.21M

Cash Flow

In the last 12 months, operating cash flow was -51.56 million and capital expenditures -975,397, giving a free cash flow of -52.54 million.

Operating Cash Flow	-51.56M
Capital Expenditures	-975,397
Free Cash Flow	-52.54M
FCF Per Share	-0.09

Margins

Gross margin is 100.00%, with operating and profit margins of -228.26% and -214.11%.

Gross Margin	100.00%
Operating Margin	-228.26%
Pretax Margin	-217.13%
Profit Margin	-214.11%
EBITDA Margin	-225.06%
EBIT Margin	-228.26%
FCF Margin	n/a

Dividends & Yields

ASX:PYC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.16%
Shareholder Yield	n/a
Earnings Yield	-6.74%
FCF Yield	-7.04%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 15, 2024. It was a reverse split with a ratio of 0.1.

Last Split Date	Nov 15, 2024
Split Type	Reverse
Split Ratio	0.1

Scores

ASX:PYC has an Altman Z-Score of 28.91 and a Piotroski F-Score of 1.

Altman Z-Score	28.91
Piotroski F-Score	1